Aberrant activation of ALK has been described in a range of human cancers, including anaplastic large cell lymphoma, non-small cell lung cancer, neuroblastoma, inflammatory myofibroblastic tumors, colorectal cancer, and so on 28. This evidence concerns the gene ALK and colorectal cancer.